Homocysteine synthase inhibitor

Details for Australian Patent Application No. 2009234703 (hide)

Owner Mitsubishi Tanabe Pharma Corporation

Inventors Suzuki, Hiroko; Iwasaki, Hiroshi; Nakao, Akira; Seki, Maki; Tanaka, Minoru; Tatsumi, Ryo; Setsuta, Tomofumi

Agent Griffith Hack

Pub. Number AU-A-2009234703

PCT Pub. Number WO2009/125853

Priority 2008-102924 10.04.08 JP

Filing date 10 April 2009

Wipo publication date 15 October 2009

International Classifications

C07C 237/10 (2006.01) Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups

A61K 31/277 (2006.01)

A61K 31/404 (2006.01)

A61K 31/4155 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/4196 (2006.01) - 1,2,4-Triazoles

A61K 31/422 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/423 (2006.01) - condensed with carbocyclic rings

A61K 31/4245 (2006.01) - Oxadiazoles

A61K 31/427 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/433 (2006.01) - Thiadiazoles

A61K 31/4439 (2006.01)

A61K 31/454 (2006.01)

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/5375 (2006.01) - 1,4-Oxazines, e.g. morpholine

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07C 255/58 (2006.01) Carboxylic acid nitriles

C07D 209/44 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 271/06 (2006.01) Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms

C07D 295/22 Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

Event Publications

18 November 2010 PCT application entered the National Phase

  PCT publication WO2009/125853 Priority application(s): WO2009/125853

25 November 2010 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 21 Oct 2010

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009234734-Broadcast information notification method and network node

2009234675-Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly